EpiEndo Pharmaceuticals (private company)

See something wrong or missing? Let us know
Offices:
Reykjavik
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a proprietary portfolio of compounds with epithelial barrier enhancing properties.

Companies with similar profile to EpiEndo Pharmaceuticals:

CompanyCriteria
Sweden AttgeNO
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Pharmanest
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Ilya Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Cirqle Biomedical
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Spain Ability Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland DelSiTech
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Quretech Bio
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Avexxin
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark Ferrosan Medical Devices
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark NMD Pharma
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden TFS
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden ITBMed
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Vironova
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Asarina Pharma
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Finland Medix Biochemica
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway Vaccibody
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark STipe Therapeutics
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Gnosco
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden InfiCure Bio AB
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B